Human mutations in FoxL2 can lead to premature ovarian failure or ovarian tumors (Crisponi et al., 2001; Georges et al., 2014; Schmidt et al., 2004; Shah et al., 2009; Uda et al., 2004; Uhlenhaut and Treier, 2011). This evidence concerns the gene FOXL2 and ovarian neoplasm.